Viewing Study NCT03608657


Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2026-02-28 @ 8:19 AM
Study NCT ID: NCT03608657
Status: COMPLETED
Last Update Posted: 2024-06-05
First Post: 2018-05-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the Real-World Effectiveness, Safety and Tolerability of Treatment With Apremilast in Psoriatic Arthritis Patients Followed in Canadian Routine Care (APPRAISE)
Sponsor: Amgen
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CC-10004-PSA-011
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators